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Background: Identification and comparison of gene expression of Lysyl oxidase (LOX) in oral submucous fibrosis 
and controls and to determine its role in Pathogenesis of Oral submucous fibrosis.
Material and Methods: Of total sample size (n=127), the whole blood sample were collected from case and control 
group in citrate vial. It is centrifused and stored at -800C. We collected and isolated RNA from blood of case group 
(n=127) and age and sex matched control group (n=127) recruited on the basis of inclusion criteria. The cDNA was 
prepared for 127 samples which were processed for gene expression of Lysyl oxidase (LOX) in relation to house-
keeping genes (Beta actin and 18srRNA) and its role in pathogenesis of Oral submucous fibrosis.
Results: In relative expression (Normalized ratio),relatively 11 cases shown down-regulation of lysyl oxidase gene 
while 27 cases shows up-regulation of lysyl oxidase gene while in 89 cases there were no regulation i.e expression 
of lysyl oxidase gene in case group was of same degree of control. In non-relative expression results (Non-norma-
lized ratio), the 38 cases shown down regulation of LOX gene while in 53 cases, it was up-regulated however in 
remaining 36 cases there was neither up-regulation nor down-regulation of Lysyl oxidase gene i.e the expression 
of LOX gene is null.
Conclusions: In oral submucous fibrosis, the expression of Lysyl oxidase gene is mixed type i.e either it will down 
regulate/upregulate or there will be no expression at all comparatively. However in majority of cases the upregu-
lation of lysyl oxidase is relatively more common than down-regulation or non expression of Lysyl oxidase gene.
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Introduction
Oral Submucous fibrosis is a chronic debilitating disea-
se and a potentially malignant condition of oral cavity. 
The incidence of oral squamous cell carcinoma has been 
estimated to be 7.6% in oral submucous fibrosis patients 
after 17 years follow up (1). There are 200-400 million 
areca nut chewers worldwide. Areca nut associated oral 
squamous cell carcinoma is the 3rd most common ma-
lignancy in developing countries (2). Oral submucous 
fibrosis is associated exclusively with areca nut chewing 
and is believed to be a homeostatic disorder of extra-
cellular matrix (3). Epidemiological evidences strongly 
indicate association of the betel quid habit and oral sub-
mucous fibrosis. The areca nut (betel nut) component of 
betel quid especially an alkaloid called arecoline plays 
a major role in pathogenesis of oral submucous fibrosis 
by causing an abnormal increase in the collagen produc-
tion. The synthesis of collagen is influenced by a variety 
of mediators, prominent mediator being transforming 
growth factor-beta (TGF-beta). The TGF-beta1 in par-
ticular seems to be the one that plays a major role in 
wound repair and fibrosis. It causes the deposition of ex-
tra-cellular matrix by increasing the synthesis of matrix 
proteins like collagen and decreasing its degradation by 
stimulating various inhibitory mechanisms (1). TGF- 
beta has been found to strongly promote the expression 
of Lysyl oxidase (LOX) both at mRNA and protein 
levels in various cell lines (1). The LOX is dependent 
on copper for its functional activity (1).Arecanuts have 
been shown to have a high copper content and chewing 
areca nuts for 5 to 30 minutes significantly increases so-
luble copper levels in oral fluids. The increased level of 
soluble copper could act as an important factor in oral 
submucous fibrosis by stimulating fibrogenesis throu-
gh upregulation of LOX activity (4). Previous studies 
have specified the upregulation of LOX expression in 
normal oral keratinocytes by arecanut extract and its 
oncogenesis for oral squamous cell carcinoma (5). The-
re are 7 single nucleotide polymorphism (SNP) sites in 
LOX coding region including C225G,G409C,G473A,-
C476A,G816A,T924G and A1135G2. Among all the 
SNP sites in LOX coding region G473A has the highest 
polymorphic frequency. The genetic susceptibility or di-
seases nature of oral submucous fibrosis is still largely 
undefined2.The present study is designed to investiga-
te the presence of LOXG473A gene expression in Oral 
submucous fibrosis patients and its role in development 
of oral cancer.
Material and Methods
The study subjects (n=127) were recruited from the 
OPD Department of Oral medicine and Radiology, 
King George Medical University, Lucknow, India. A 
structured questionnaire was used to record all neces-
sary data. The ethical clearance is obtained from Ins-
titutional Ethics Committee of King George Medical 
University, Lucknow, India.  The study subjects having 
clinically and histopathologically diagnosed oral sub-
mucous fibrosis, betel quid chewing habit without cli-
nical evidence of oral submucous fibrosis and healthy 
individuals without betel quid chewing habit and having 
normal oral mucosa were included in study however the 
patients who are on regular analgesics or anti-inflam-
matory drugs which are known to interfere with Lysyl 
oxidase activity and patients who have already received 
or on treatment for oral submucous fibrosis is excluded 
from study. The study population is divided in 2 groups. 
Group 1 includes study subjects with clinically and his-
topathologically proven oral submucous fibrosis (Case 
group) and group 2 includes study subjects without Oral 
submucous fibrosis (Control group). A written consent 
was obtained from each participant in study. The whole 
blood sample was collected from case and control group 
in citrate vial. It was centrifused and stored at -800C. We 
collected and isolated RNA from blood of case group 
(n=127) and age and sex matched control group (n=127) 
recruited on the basis of inclusion criteria.
a. RNA extraction. This study was done by isolating 
RNA by using trizol method which is mentioned below-
Take 200 ul of blood and 1 ul trizol in 1.5 ml tube and 
vortex it for 2 min → Keep it on room temperature for 2 
min→ Now spin the sample on 12000g for 10 minutes at 
4 degree→ Collect the supernatant→ Add 250 ul chloro-
form→ Mix it 200 times by hand→ Keep on RT for 15 
min→ Spin at 12000g for 10 min→3 layers will appear 
(upper Aqueous layer=RNA, Middle white layer=DNA, 
Bottom layer=Protein) → Collect upper Aqueous la-
yer→ Add 500 microlitre of isopropanol in other tube→ 
Mix 100 times by hand→ Spin at 12000g for 15 mins→ 
Discard the supernatant(Take another tube and transfer 
collection in it ) → Add 500 microlitre of 70% alcohol→ 
Spin at 12000g for 10 mins→ Add 500 microlitre of 70% 
alcohol→ Spin at 12000g for 10 mins→ Discard the su-
pernatant and spin for 1 min→ Remove extra liquid by 
pipette→ Keep it for 5 min at RT→ Add 25microlitre of 
RNAse free water→ Keep it for 20 min at RT→ Store it 
at -20 degree.
The cDNA was prepared for 127 samples which were 
processed for gene expression of Lysyl oxidase (LOX) in 
relation to housekeeping genes (Beta actin and 18srRNA) 
and its role in pathogenesis of Oral submucous fibrosis.
b. cDNA Synthesis. The first strand cDNA will be syn-
thesized by annealing 2 μg of RNA with 0.5 μg of oligo 
d(T)18 primer in a total reaction volume of  20 μl using 
M-MLV reverse transcriptase. The mixture will be in-
cubated for one hour at 37 °C, further the enzyme will 
be deactivated by heating at 95 °C for five minutes. Tar-
geted and housekeeping gene specific primers will be 
validated through gradient PCR and will be used for re-
al-time PCR amplifications (ABI-Step One).  
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c. Real Time PCR. Briefly, 0.5 μl cDNA, 10 pmol of each 
PCR-validated primers and 10 μl SYBR Green master 
mix in a final volume of 20 μl with a negative control 
(no template) will be subjected to activation step at 95 
°C for 10 min, followed by 40 cycles of : 15 s at 95 °C, 
15 s at the Tm (specific for the primer pairs used), 1min 
at 59°C with a single fluorescence measurement. After 
the amplification phase, a melting curve cycle will be 
set at 95 °C for 15 s, 59 °C for 1 min with a continuous 
measurement to confirm later about the amplification of 
a single product. Real time PCR will be repeated thrice 
for each sample. The relative level of each transcript in 
different sample will be calculated by normalization of 
the value with the corresponding reference and will also 
be compared with the Ct values of positive calibrator. 
Results
Of total sample size (n=150), the whole blood sample 
were collected from case and control group in citrate 
vial. It is centrifused and stored at -800C. We collected 
and isolated RNA from blood of case group (n=127) and 
age and sex matched control group (n=127) recruited on 
the basis of inclusion criteria. The cDNA was prepared 
for 127 samples which were processed for gene expres-
sion of Lysyl oxidase (LOX) in relation to housekeeping 
genes (Beta actin and 18srRNA) and its role in pathoge-
nesis of Oral submucous fibrosis. The crossing point, Ct 
values were acquired for both the target and reference 
gene using ABI Stepone RT-PCR software. The relative 
level of each transcript in different samples was calcula-
ted by normalization of the value with the corresponding 
reference and compared among them using Ct values for 
Case 1 cDNA as positive calibrator. Comparison of the 
relative expression level of each transcript was analyzed 
by REST 2009 software with 2000 time iterations.
In relative expression (Normalized ratio),relatively 11 
cases shown down-regulation of lysyl oxidase gene whi-
le 27 cases shows up-regulation of lysyl oxidase gene 
while in 89 cases there were no regulation i.e expression 
of lysyl oxidase gene in case group was of same degree 
of control.  So it was concluded that in case group the 
up-regulation of lysyl oxidase was more common than 
down-regulation comparatively. However either of upre-
gulation or down regulation is statistically significant 
(p<.001). In non-relative expression results (Non-nor-
malized ratio), the 38 cases shown down regulation of 
LOX gene while in 53 cases, it was up-regulated howe-
ver in remaining 36 cases there was neither up-regula-
tion nor down-regulation of Lysyl oxidase gene i.e the 
expression of LOX gene is null. The down-regulation 
and up-regulation of lysyl oxidase gene was statistically 
significant (P<.001) (Figs. 1-4).
In oral submucous fibrosis, the expression of Lysyl oxi-
dase gene is mixed type i.e either it will down regulate/
up-regulate or there will be no expression at all com-
paratively. However in majority of cases the upregula-
tion of lysyl oxidase is relatively more common than 
down-regulation or non expression of Lysyl oxidase 
gene. So the expression of lysyl oxidase gene can be 
used as adjunctive diagnostic tool for oral submucous 
fibrosis.As the expression of lysyl oxidase gene is mixed 
type in our study, we are not in agreement with previous 
studies that the lysyl oxidase gene is only upregulated. 
We cannot definitely say its role in pathogenesis of in 
oral submucous fibrosis however more studies are nee-
ded in this field to reach a definite conclusion.
Fig. 1: Whisker plot diagram shows comparative relative expression of the LOX gene in samples no 1to 38.
J Clin Exp Dent. 2019;11(10):e858-64.                            Lysyl oxidase gene (LOXG473A) expression in pathogenesis and malignant transformation of Oral Submucous Fibrosis
e861
Fig. 2: Whisker plot diagram shows comparative relative expression of the LOX gene in samples no 39 to 74.
Fig. 3: Whisker plot diagram shows comparative relative expression of the LOX gene in samples no 75 to 110.
Fig. 4: Whisker plot diagram shows comparative relative expression of the LOX gene in samples no 111 to 127.
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Discussion
Oral submucous fibrosis (OSF) is characterized by a 
general fibrotic change in the oral submucosa and the 
progressive tissue rigidity resulting in diffculties in 
mouth-opening, tongue movement, intolerance to spicy 
food and rigidity of the lip (7). OSF is associated ex-
clusively with areca chewing and was believed to be a 
homeostatic disorder of extracellular matrix (ECM) (8). 
OSF is predominately seen in people in South Asian 
countries, or South Asian (9). It is now a public health 
issue in many parts of the world, including the United 
Kingdom (10), South Africa (11) and many South East 
Asian countries (12,13).
The common hypothesis for OSF pathogenesis is the in-
crease of collagen synthesis or reduced collagen degra-
dation in oral sub-epithelial tissues because of chemical, 
physical or inflammatory irritation. Although the availa-
ble epidemiological evidence indicates that  the chewing 
of the areca nut is an important risk for developing of 
OSF (14-16). Not all chewers  develop  the disease. 
Other information, however, indicates that the disea-
se is not necessarily dose-response related and genetic 
predisposition might explain such individual variability 
(16). Also, cessation of the habit also does not influence 
the characteristics of the disease once it is established 
(17). Diverse disruptions in inflammatory cytokines and 
ECM organizers are involved in the pathogenic pro- ces-
ses. OSF patients expressed higher tissue inhibitors of 
metalloproteinases-1 (TIMP1) and lower matrix metal- 
loproteinases-2 (MMP2) cause stabilization of extra- 
cellular matrix (7,18,19). Tannins purified from areca 
can make collagen resistance to collagenase (20). The 
inflammatory effect of OSF  is associated  with  COX-
2 (21) which can induce prostaglandin as inflammatory 
mediator. Cytokines such as transforming growth fac-
tor (TGF)-b, IL-1, IL-6, platelet-derived growth factor 
(PDGF)   and   basic   fibroblast   growth   factor (bFGF) 
are up regulated in OSF than normal group (7,22). Are-
coline, the major alkaloid in areca, can induce the syn-
thesis of collagen (23). A recent report demonstrated that 
the treatment with collagenase reduced the symp- toms 
of OSF (24). In addition, genetic polymorphisms in 
TNF-a, MMP-3, major histocompatibility complex class 
I chain related gene A (MICA), and cytotoxic T- lym-
phocyte associated antigen 4 (CTLA-4), which are asso-
ciated with ECM organization or inflammation are risk 
factors to OSF (25-28). Lysyl oxidase (LOX) is a copper- 
activated enzyme critical for collagen cross-linking and 
organization of extracellular matrix. The presence of a 
G to A polymorphism at nucleotide 473 caused a non- 
conservative Arg158Gln change in the LOX amino acid 
sequence. OSF is a precancerous lesions characterized 
by the accumulation of collagen in oral submocousa 
(29). Shieh et al. (30), conducted a study on Taiwan 
population to find the association between LOX gene 
polymorphism and OSMF in older male areca chewers. 
The presence of G to A polymorphism at nucleotide at 
473, caused a non-conservative Arg158Gln change in 
the LOX amino acid sequence. They investigated the re-
lationship between LOX Arg158Gln polymorphism and 
risk of OSMF. There was a borderline statistical signifi-
cant difference in Arg158Gln genotype between control 
and OSMF patients. However, the G/A + A/A of LOX 
Arg158Gln in OSMF patients older than 50 years was 
statistically significantly higher than controls below 50 
years. In study conducted by Shieh et al., (30) on Taiwan 
population, the mean duration of areca chewing habit in 
patients less than 50 years and more than 50 years was 
15 years and 21 years, respectively. Shieh et al., (31) 
identified an upregulation of LOX and LOXL2 mRNA 
expression in areca-associated OSCC tissues and cell li-
nes relative to their normal counterparts. Other previous 
investigations that focused mostly on breast carcinomas, 
identified that LOX can induce migration and invasion 
of malignant breast epithelial cells. Shieh et al. (30) in 
his study included sample size of 83 OSMF patients and 
216 areca chewers without OSMF as control. In the pre-
sent study, the sample size included was 20 OSMF pa-
tients and 20 areca chewers without OSMF. The absence 
of LOX gene polymorphism in the present study could 
also be attributed to the smaller sample size. This neces-
sitates further studies with larger sample size.Another 
possible explanation for the variation in the LOX gene 
polymorphism between Taiwan population and Indian 
population could be the difference in genetic makeup. 
LOX is a cuproenzyme that is essential for stabilization 
of extracellular matrixes, specifically the enzymatic 
cross-linking of collagen and elastin. Copper is essential 
for organic cofactor formation in lysyl oxidase (32).  
Areca products contain high levels of copper (mean 302 
nmol/g). Hence local factors such as composition of the 
quid, consistency of quid, duration and frequency of 
habit and whether saliva is expelled or swallowed after 
chewing, can affect the uptake of copper into the oral 
epithelium (33). These factors may explain the marked 
variations seen in the copper levels within the OSMF 
group which in turn may affect the regulation of LOX 
gene and its polymorphism in OSMF patients. Howe-
ver, in the present study these factors were not consi-
dered.LOX coding region contains seven single nucleo-
tide polymorphism (SNP) sites that includes C225G, 
G409C, G473A, C476A, G816A, T924G and A1135G. 
Among all the SNP sites in LOX coding region, G473A 
has the highest polymorphic frequency (30). 
These  results  demonstrate  that  LO  expression  is 
upregulated  in  OSF  as  in other fibrotic diseases such 
as fibrosis of the liver. In the OSF cases the distribution 
of LO positivity was closely associated with collagen in 
the juxta-epithelial lamina propria and submucosa and 
was identified as a secreted protein localized mostly in 
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the extracellular matrix. It is therefore feasible to sug-
gest that the excessive   deposition   of   heavily   cross-
linked collagen seen in OSF  may be impart  due  to  an 
increase  in  the  activity of LO. Collagen deposition in 
the early stages of fibrogenesis in murine schistosomia-
sis is associated with upregulation of  LO (34).
The   mechanism   of   this upregulation by  fibroblasts 
in  OSF  is not  fully  understood.  Cytokine  mediators 
such  as  IL-1,  TGF-b and  EGF have been shown to 
increase LO activity in smooth muscle cultures (35) and 
immunohistochemically   detectable   levels of  IL-1a 
and b ,  IL-6,  IFN,  TGF-b,PDGF and FGFb have been 
shown to be increased in OSF tissues (36).
Our data show an inverse relationship between the se-
verity of the fibrosis and the expression of LO. In early 
cases of OSF, as measured by mouth opening more than 
30 mm, there is intense LO staining and this tends to 
decrease  as the severity of fibrosis progresses. This may 
suggest that LO expression is related to active elastin 
and collagen syn- thesis early in the disease process. In 
cases with mouth opening below 30 mm, the level of 
LO immunopositivity is lower suggesting that much of 
the fibrosis has already taken place. This would support 
the hypothesis that the accumulation of collagen seen in 
ad- vanced cases of OSF is not only due to fibrogenesis, 
but may also be due to a decrease in the breakdown of 
the colla- gen earlier cross-linked by lysyl oxidase, and 
thus a reduced overall turnover. It would be desirable to 
look at LO expression in earlier stages of OSF, such as 
in blanching of mucosa, to confirm these findings (33). 
It has been shown that the amount of dietary or cellular 
copper can markedly influence the functional activity 
of LO (37,38) and that levels of dietary copper intake 
influence skin lysyl oxidase in young men39. It is there-
fore possible that the excess copper from areca nut may 
upregulate LO activity in oral mucosa, resulting in fi-
brosis. The precise mechanism by which this occurs is 
not fully understood. LO has a relatively short half-life 
and it is expressed transiently, as shown in developing 
granulomas in murine schistosomiasis (34).
One possible explanation is that the enzyme activity 
may be stabilised by copper, thus increasing its half-li-
fe. Sec- ondly, at the molecular level, the N-terminus of 
exon 1 of the LO molecule has copper binding sites, and 
this interaction may upregulate the expression of the en-
zyme at the cellular level. Further studies are in progress 
to investigate LO activity of oral fibroblasts following 
ex posure to copper in vitro.Based on our previous ob-
servations that copper is released from areca prod- ucts 
during chewing and is deposited in oral tissues, taken 
together with our current findings that LO activity is 
up- regulated in OSF, we hypothesize that these cellular 
events lead to cross- linking of collagen and elastin, thus 
making them less degradable. The upregulation of LO in 
OSF may be an important factor in the pathogenesis and 
progression of this disorder and merits further detailed 
study (33).
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Real-Time PCR:  Ct  (threshold cycle) is the intersection between an 
amplification curve and a threshold line.
